Search results: found 6 materials
14 Mar 2023
Rostec to Deliver 800,000 Measles Vaccine Doses to the Russian Regions
The campaign is focused on the immunization of social groups not covered by the standard vaccination procedure
14 Dec 2022
Natsimbio is Launching a New Drug for the Treatment of Immunodeficiencies
BioGam drug will substitute for its foreign analogues and increase the availability and quality of therapy
20 Jun 2022
The Human Stem Cell Institute and Rostec are Developing Influenza and COVID-19 Vaccine
Clinical study of the combination vaccine formulation is to be started in the second half of the year
14 Dec 2017
Microgen Developed Drug for ICP Treatment
The first Russian made drug for cerebral palsy caused spastic ailment treatment is abreast with the oversees counterparts
8 Dec 2017
Nacimbio to Showcase Key Projects and New Development
The pharmaceutical holding company participates in the “PharmMedProm-2017” exhibition
19 Sep 2017
Nacimbio Participated in Panel Discussions at the BIOTECHMED
Special attention was paid to the need for transition to multicomponent prophylactic drugs
